Sun Pharmaceutical Industries Ltd.

The sales slipped to Rs. 44660.70 millions for the June 2023 quarter as against Rs. 49328.80 millions during the year-ago period.The Net Profit of the company slipped to Rs. 3806.40 millions from Rs. 10118.00 millions, a decline of -62.38% on QoQ basis.A decline of 11123.00 millions was observed in the OP in the quarter ended June 2023 from 14986.50 millions on QoQ basis.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202306	202206	% Var	202306	202206	% Var	202303	202203	% Var
Sales	44660.70	49328.80	-9.46	44660.70	49328.80	-9.46	208121.40	155859.80	33.53
Other Income	1635.40	1762.10	-7.19	1635.40	1762.10	-7.19	3292.90	11968.80	-72.49
PBIDT	11123.00	14986.50	-25.78	11123.00	14986.50	-25.78	67518.90	38654.40	74.67
Interest	1579.40	870.70	81.39	1579.40	870.70	81.39	4721.80	3881.00	21.66
PBDT	8051.50	14115.80	-42.96	8051.50	14115.80	-42.96	33419.20	16568.10	101.71
Depreciation	4152.70	3745.00	10.89	4152.70	3745.00	10.89	16008.70	13499.50	18.59
PBT	3898.80	10370.80	-62.41	3898.80	10370.80	-62.41	17410.50	3068.60	467.38
TAX	92.40	252.80	-63.45	92.40	252.80	-63.45	503.30	4068.50	-87.63
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	3806.40	10118.00	-62.38	3806.40	10118.00	-62.38	16907.20	-999.90	-1790.89
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	24.91	30.38	-18.02	24.91	30.38	-18.02	32.44	24.80	30.81